1,25-Dihydroxyvitamin_NN
D3_NN
receptor_NN
RNA_NN
:_:
expression_NN
in_IN
hematopoietic_JJ
cells_NNS
._.

1,25-Dihydroxyvitamin_NN
D3_NN
-LCB-_-LRB-
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
-RCB-_-RRB-
induces_VBZ
differentiation_NN
and_CC
inhibits_VBZ
proliferation_NN
of_IN
myeloid_JJ
leukemic_JJ
cells_NNS
from_IN
various_JJ
lines_NNS
and_CC
patients_NNS
;_:
these_DT
effects_NNS
are_VBP
probably_RB
mediated_VBN
through_IN
the_DT
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
._.

Little_JJ
is_VBZ
known_VBN
of_IN
expression_NN
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
RNA_NN
in_IN
hematopoietic_JJ
cells_NNS
._.

We_PRP
examined_VBD
the_DT
expression_NN
and_CC
modulation_NN
of_IN
expression_NN
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
RNA_NN
in_IN
various_JJ
proliferating_VBG
and_CC
nonproliferating_JJ
hematopoietic_JJ
cells_NNS
._.

Constitutive_JJ
expression_NN
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
RNA_NN
was_VBD
detected_VBN
in_IN
various_JJ
kinds_NNS
of_IN
hematopoietic_JJ
cells_NNS
,_,
including_VBG
macrophages_NNS
and_CC
activated_VBN
T_NN
lymphocytes_NNS
,_,
as_RB
well_RB
as_IN
in_IN
cell_NN
lines_NNS
KG-1_NN
-LRB-_-LRB-
myeloblasts_NNS
-RRB-_-RRB-
,_,
HL-60_NN
-LRB-_-LRB-
promyelocytes_NNS
-RRB-_-RRB-
,_,
ML-3_NN
-LRB-_-LRB-
myelomonoblasts_NNS
-RRB-_-RRB-
,_,
U937_NN
,_,
THP-1_NN
-LRB-_-LRB-
monoblasts_NNS
-RRB-_-RRB-
,_,
K562_NN
-LRB-_-LRB-
erythroblasts_NNS
-RRB-_-RRB-
,_,
and_CC
S-LB1_NN
-LRB-_-LRB-
HTLV-1-transfected_JJ
T_NN
lymphocytes_NNS
-RRB-_-RRB-
._.

Receptor_NN
transcripts_NNS
were_VBD
4.6_CD
kilobases_NNS
-LRB-_-LRB-
kb_NN
-RRB-_-RRB-
,_,
and_CC
no_DT
variant_JJ
sizes_NNS
were_VBD
observed_VBN
._.

All_DT
cell_NN
lines_NNS
examined_VBN
in_IN
this_DT
group_NN
also_RB
expressed_VBD
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptors_NNS
._.

Most_JJS
B_NN
lymphocyte_NN
lines_NNS
expressed_VBD
negligible_JJ
levels_NNS
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
RNA_NN
and_CC
protein_NN
;_:
however_RB
;_:
analysis_NN
of_IN
a_DT
lymphoid\/myeloid_JJ
somatic_JJ
hybrid_NN
suggested_VBD
that_IN
suppression_NN
of_IN
expression_NN
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
RNA_NN
in_IN
B_NN
lymphocytes_NNS
may_MD
be_VB
a_DT
dominant_JJ
characteristic_NN
._.

HL-60_NN
cells_NNS
were_VBD
cultured_VBN
with_IN
10_CD
-LRB-_-LRB-
-7_CD
-RRB-_-RRB-
mol\/L_NN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
for_IN
24_CD
to_TO
72_CD
hours_NNS
,_,
and_CC
levels_NNS
of_IN
expression_NN
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
and_CC
its_PRP$
RNA_NN
were_VBD
examined_VBN
._.

Levels_NNS
of_IN
RNA_NN
coding_VBG
for_IN
the_DT
receptor_NN
were_VBD
not_RB
modulated_VBN
by_IN
exposure_NN
to_TO
high_JJ
levels_NNS
of_IN
ligand_NN
._.

Levels_NNS
of_IN
occupied_NN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
protein_NN
increased_VBD
in_IN
these_DT
HL-60_NN
cells_NNS
;_:
but_CC
the_DT
total_JJ
number_NN
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptors_NNS
decreased_VBD
about_RB
50_CD
%_NN
at_IN
24_CD
hours_NNS
and_CC
returned_VBD
toward_IN
normal_JJ
at_IN
72_CD
hours_NNS
._.

Steady-state_JJ
levels_NNS
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
RNA_NN
were_VBD
not_RB
affected_VBN
by_IN
terminal_JJ
differentiation_NN
of_IN
HL-60_NN
toward_IN
either_CC
granulocytes_NNS
or_CC
macrophages_NNS
._.

Nondividing_JJ
macrophages_NNS
from_IN
normal_JJ
individuals_NNS
also_RB
expressed_VBD
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
RNA_NN
._.

In_IN
contrast_NN
,_,
nondividing_JJ
peripheral_JJ
blood_NN
lymphocytes_NNS
from_IN
normal_JJ
individuals_NNS
did_VBD
not_RB
express_VB
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
RNA_NN
;_:
with_IN
stimulation_NN
of_IN
proliferation_NN
of_IN
these_DT
cells_NNS
,_,
accumulation_NN
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
RNA_NN
increased_VBD
markedly_RB
._.

Half-life_NN
-LRB-_-LRB-
t1\/2_NN
-RRB-_-RRB-
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
RNA_NN
in_IN
T_NN
lymphocytes_NNS
was_VBD
short_JJ
-LRB-_-LRB-
1_CD
hour_NN
-RRB-_-RRB-
as_IN
determined_VBN
by_IN
measuring_VBG
decay_NN
of_IN
the_DT
message_NN
after_IN
addition_NN
of_IN
actinomycin_NN
D_NN
._.

Consistent_JJ
with_IN
this_DT
short_JJ
t1\/2_NN
,_,
accumulation_NN
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
RNA_NN
increased_VBD
in_IN
cells_NNS
as_IN
their_PRP$
protein_NN
synthesis_NN
was_VBD
inhibited_VBN
._.

Further_JJ
studies_NNS
are_VBP
required_VBN
to_TO
understand_VB
the_DT
physiologic_JJ
role_NN
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptors_NNS
in_IN
myeloid_JJ
cells_NNS
and_CC
proliferating_VBG
T_NN
lymphocytes_NNS
._.

